ABOUT THE SPEAKER
Elizabeth Wayne - Biomedical engineer
TED Fellow Dr. Elizabeth Wayne is a biomedical engineer and advocate for women in higher education.

Why you should listen
Dr. Elizabeth Wayne received her Bachelor's degree in Physics from the University of Pennsylvania, where she was a Ronald E. McNair Scholar and Moelis Access Science Scholar. She continued her education at Cornell University, where her research on the role of immune cells in cancer progression and their potential as drug delivery carriers was supported by funding from the National Cancer Institute Physical Sciences in Oncology Network and the Howard Hughes Medical Institute. In 2016, Wayne earned her PhD in biomedical engineering, where her work in immune cell-mediated drug delivery resulted in several publications and a technology patent. Her current research uses macrophages to delivery therapeutic genes to solid tumors.

Wayne is a strong advocate for women in science. She has been a chief organizer for the Conference for Undergraduate Women in Physics (CUWIP) at Cornell as well as a panelist and workshop leader at CUWiPs held at Yale and Harvard. She has received awards for her advocacy including the Constance and Alice Cook Award.

Wayne is currently a National Cancer Institute Cancer Nanotechnology Training Program Postdoctoral Fellow in the Eshelman School of Pharmacy at UNC-Chapel Hill. She was recognized as a 2017 TED Fellow for her cancer nanotechnology research and efforts to amplify voices of women in leadership and higher education through her podcast PhDivas. Wayne has been featured in various publications including Bust Magazine, Cornell Chronicle and the Los Angeles Times.

As a speaker, Wayne works with high schools, colleges and nonprofit organizations across the country to encourage the inclusion of women in science.
More profile about the speaker
Elizabeth Wayne | Speaker | TED.com
TED2017

Elizabeth Wayne: We can hack our immune cells to fight cancer

Filmed:
1,452,700 views

After decades of research and billions spent in clinical trials, we still have a problem with cancer drug delivery, says biomedical engineer Elizabeth Wayne. Chemotherapy kills cancer -- but it kills the rest of your body, too. Instead of using human design to fight cancer, why not use nature's? In this quick talk, Wayne explains how her lab is creating nanoparticle treatments that bind to immune cells, your body's first responders, to precisely target cancer cells without damaging healthy ones.
- Biomedical engineer
TED Fellow Dr. Elizabeth Wayne is a biomedical engineer and advocate for women in higher education. Full bio

Double-click the English transcript below to play the video.

00:12
After decades of research
0
873
2033
00:14
and billions of dollars
spent in clinical trials,
1
2930
3269
00:18
we still have a problem
with cancer drug delivery.
2
6223
3178
00:22
We still give patients chemotherapy,
3
10586
2144
00:24
which is so non-specific
4
12754
1833
00:26
that even though
it kills the cancer cells,
5
14611
2526
00:29
it kind of kills
the rest of your body, too.
6
17161
2285
00:32
And yes, we have developed
more selective drugs,
7
20494
3456
00:35
but it's still a challenge
to get them into the tumor,
8
23974
2703
00:38
and they end up accumulating
in the other organs as well
9
26701
2916
00:41
or passing through your urine,
10
29641
1631
00:43
which is a total waste.
11
31296
1781
00:46
And fields like mine have emerged
12
34389
1970
00:48
where we try to encapsulate these drugs
13
36383
1966
00:50
to protect them as they
travel through the body.
14
38373
2553
00:52
But these modifications cause problems
15
40950
2853
00:55
that we make more modifications to fix.
16
43827
2425
00:58
So what I'm really trying to say
is we need a better drug delivery system.
17
46961
4528
01:03
And I propose,
18
51513
1416
01:04
rather than using solely human design,
19
52953
2631
01:07
why not use nature's?
20
55608
1635
01:10
Immune cells are these versatile vehicles
that travel throughout our body,
21
58309
3854
01:14
patrolling for signs of disease
22
62187
2102
01:16
and arriving at a wound
mere minutes after injury.
23
64313
3144
01:20
So I ask you guys:
24
68000
1419
01:22
If immune cells are already traveling
to places of injury or disease
25
70054
3381
01:25
in our bodies,
26
73459
1153
01:26
why not add an extra passenger?
27
74636
1657
01:28
Why not use immune cells to deliver drugs
28
76966
2927
01:31
to cure some of our biggest problems
29
79917
1962
01:33
in disease?
30
81903
1398
01:36
I am a biomedical engineer,
31
84446
1909
01:38
and I want to tell you guys a story
about how I use immune cells
32
86379
3001
01:41
to target one of the largest
problems in cancer.
33
89404
3235
01:44
Did you know that over 90 percent
of cancer deaths
34
92663
2507
01:47
can be attributed to its spread?
35
95194
1751
01:48
So if we can stop these cancer cells
36
96969
2265
01:51
from going from the primary tumor
to a distant site,
37
99258
3074
01:54
we can stop cancer right in its tracks
38
102356
2476
01:56
and give people more of their lives back.
39
104856
2183
02:00
To do this special mission,
40
108182
1580
02:01
we decided to deliver
a nanoparticle made of lipids,
41
109786
3050
02:04
which are the same materials
that compose your cell membrane.
42
112860
3233
02:08
And we've added two special molecules.
43
116733
2344
02:11
One is called e-selectin,
44
119952
2177
02:14
which acts as a glue
45
122153
1276
02:15
that binds the nanoparticle
to the immune cell.
46
123453
3331
02:19
And the second one is called trail.
47
127223
2493
02:21
Trail is a therapeutic drug
that kills cancer cells
48
129740
2656
02:24
but not normal cells.
49
132420
1245
02:26
Now, when you put both of these together,
50
134392
2802
02:29
you have a mean killing machine on wheels.
51
137218
2865
02:35
To test this, we ran
an experiment in a mouse.
52
143589
2573
02:39
So what we did was we injected
the nanoparticles,
53
147276
3065
02:42
and they bound almost immediately
to the immune cells in the bloodstream.
54
150365
4017
02:46
And then we injected the cancer cells
to mimic a process
55
154406
2925
02:49
through which cancer cells
spread throughout our bodies.
56
157355
3151
02:52
And we found something very exciting.
57
160530
2132
02:55
We found that in our treated group,
58
163620
2670
02:58
over 75 percent of the cancer cells
we initially injected were dead or dying,
59
166314
4780
03:03
in comparison to only around 25 percent.
60
171118
2697
03:05
So just imagine: these fewer
amount of cells were available
61
173839
3182
03:09
to actually be able to spread
to a different part of the body.
62
177045
3112
03:12
And this is only after
two hours of treatment.
63
180181
2717
03:14
Our results were amazing,
and we had some pretty interesting press.
64
182922
4306
03:19
My favorite title was actually,
65
187974
2250
03:22
"Sticky balls may stop
the spread of cancer."
66
190248
2614
03:24
(Laughter)
67
192886
1093
03:26
I can't tell you just how smug
my male colleagues were,
68
194003
4008
03:30
knowing that their sticky balls
might one day cure cancer.
69
198035
2973
03:33
(Laughter)
70
201032
2298
03:35
But I can tell you they made
some pretty, pretty, exciting,
71
203354
3402
03:38
pretty ballsy t-shirts.
72
206780
1298
03:40
This was also my first experience
talking to patients
73
208595
4216
03:44
where they asked how soon
our therapy would be available.
74
212835
2893
03:48
And I keep these stories with me
to remind me of the importance
75
216279
3145
03:51
of the science,
the scientists and the patients.
76
219448
2947
03:55
Now, our fast-acting results
were pretty interesting,
77
223809
2541
03:58
but we still had one lingering question:
78
226374
2133
04:00
Can our sticky balls,
79
228531
1696
04:02
our particles actually attached
to the immune cells,
80
230251
2683
04:04
actually stop the spread of cancer?
81
232958
1941
04:07
So we went to our animal model,
and we found three important parts.
82
235624
4276
04:12
Our primary tumors were smaller
in our treated animals,
83
240615
3018
04:15
there were fewer cells in circulation,
84
243657
2518
04:18
and there was little to no
tumor burden in the distant organs.
85
246199
3466
04:22
Now, this wasn't just a victory
for us and our sticky balls.
86
250835
3878
04:26
This was also a victory to me
87
254737
2107
04:28
in drug delivery,
88
256868
1255
04:30
and it represents a paradigm shift,
89
258147
1931
04:32
a revolution --
90
260102
1246
04:34
to go from just using drugs,
just injecting them
91
262330
3380
04:37
and hoping they go to the right
places in the body,
92
265734
2453
04:40
to using immune cells
as special delivery drivers in your body.
93
268211
4991
04:45
For this example, we used two molecules,
e-selectin and trail,
94
273975
3716
04:49
but really, the possibility
of drugs you can use are endless.
95
277715
3784
04:53
And I talked about cancer,
96
281523
2394
04:55
but where disease goes,
so do immune cells.
97
283941
2662
04:59
So this could be used for any disease.
98
287600
2415
05:02
Imagine using immune cells
to deliver crucial wound-healing agents
99
290039
4679
05:06
after a spinal cord injury,
100
294742
1842
05:09
or using immune cells to deliver drugs
past the blood-brain barrier
101
297474
4397
05:13
to treat Parkinson's
or Alzheimer's disease.
102
301895
2361
05:17
These are the ideas that excite me
about science the most.
103
305044
3049
05:20
And from where I stand,
I see so much promise and opportunity.
104
308710
3447
05:24
Thank you.
105
312181
1190
05:25
(Applause)
106
313395
3541

▲Back to top

ABOUT THE SPEAKER
Elizabeth Wayne - Biomedical engineer
TED Fellow Dr. Elizabeth Wayne is a biomedical engineer and advocate for women in higher education.

Why you should listen
Dr. Elizabeth Wayne received her Bachelor's degree in Physics from the University of Pennsylvania, where she was a Ronald E. McNair Scholar and Moelis Access Science Scholar. She continued her education at Cornell University, where her research on the role of immune cells in cancer progression and their potential as drug delivery carriers was supported by funding from the National Cancer Institute Physical Sciences in Oncology Network and the Howard Hughes Medical Institute. In 2016, Wayne earned her PhD in biomedical engineering, where her work in immune cell-mediated drug delivery resulted in several publications and a technology patent. Her current research uses macrophages to delivery therapeutic genes to solid tumors.

Wayne is a strong advocate for women in science. She has been a chief organizer for the Conference for Undergraduate Women in Physics (CUWIP) at Cornell as well as a panelist and workshop leader at CUWiPs held at Yale and Harvard. She has received awards for her advocacy including the Constance and Alice Cook Award.

Wayne is currently a National Cancer Institute Cancer Nanotechnology Training Program Postdoctoral Fellow in the Eshelman School of Pharmacy at UNC-Chapel Hill. She was recognized as a 2017 TED Fellow for her cancer nanotechnology research and efforts to amplify voices of women in leadership and higher education through her podcast PhDivas. Wayne has been featured in various publications including Bust Magazine, Cornell Chronicle and the Los Angeles Times.

As a speaker, Wayne works with high schools, colleges and nonprofit organizations across the country to encourage the inclusion of women in science.
More profile about the speaker
Elizabeth Wayne | Speaker | TED.com